Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-34 - Docetaxel Plus Ramucirumab with Prophylactic PEG-G-CSF Support for Chemo-NaïVe Elderly NSCLC Patients: A Phase II Study (WJOG9416L)
16:45 - 18:00 | Presenter: Akito Hata | Author(s): Nobuyuki Katakami, Mototsugu Shimokawa, Shunichi Sugawara, Kazumi Nishino, Satoshi Hara, Hideyuki Nakagawa, Masamichi Mineshita, Motoko Tachihara, Koichi Azuma, Osamu Hataji, Hiroshi Tanaka, Toshiaki Takahashi, Toyoaki Hida, Akihiro Bessho, Eriko Tabata, Hiroshi Watanabe, Naoyuki Nogami, Toshihide Yokoyama, Hidetoshi Hayashi, Hiroaki Akamatsu, Isamu Okamoto, Tetsuya Mitsudomi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-41 - In Vitro Evaluation for Optimal MET-TKI Selection in Lung Cancers with MET Mutations Including Exon 14 Skipping
16:45 - 18:00 | Presenter: Toshio Fujino | Author(s): Kenichi Suda, Yoshihisa Kobayashi, Masaya Nishino, Takamasa Koga, Shuta Ohara, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Tetsuya Mitsudomi
- Abstract
Loading... -
+
P1.13-42 - Activity of Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance
16:45 - 18:00 | Presenter: Takamasa Koga | Author(s): Yoshihisa Kobayashi, Kenji Tomizawa, Yuichi Sesumi, Toshio Fujino, Masaya Nishino, Shuta Ohara, Masato Chiba, Masaki Shimoji, Kenichi Suda, Toshiki Takemoto, Tetsuya Mitsudomi
- Abstract
Loading...
-
+
P2.03 - Biology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.03-17 - EGFR T790M Mutation may not be Generated through Selection by EGFR-TKI from Randomly Occurring Mutations in Vitro Using ENU
16:45 - 18:00 | Presenter: Yoshihisa Kobayashi | Author(s): Tetsuya Mitsudomi
- Abstract
Loading...
-
+
P2.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.04-15 - Heterogeneity and Correlation Between Immune Markers in Lung Cancers: Analysis of Treatment-Naïve Lesions
16:45 - 18:00 | Presenter: Kenichi Suda | Author(s): Jihye Kim, Isao Murakami, Leslie Rozeboom, Christopher J. Rivard, Tetsuya Mitsudomi, Aik-Choon Tan, Fred R. Hirsch
- Abstract
Loading...
-
+
P2.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.16-03 - CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC
16:45 - 18:00 | Presenter: Enriqueta Felip | Author(s): Julie R. Brahmer, Stephen Broderick, Scott Swanson, Mark M. Awad, Tetsuya Mitsudomi, Nicolas Girard, Keith M Kerr, Jonathan David Spicer, Junliang Cai, Rong Yang, Patrick M Forde
- Abstract
Loading...
-
+
PL03 - Call to Action - Challenges Ahead
- 08:15 - 09:45
- 9/26/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track:
-
+
PL03.06 - The Future of Targeted Therapy
09:30 - 09:45 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation